News

NATURE BIOTECHNOLOGY
CANCER-NEURONAL CROSSTALK & THE STARTUPS WORKING TO SILENCE IT

FEBRUARY 7th, 2020

Investors back ‘cancer neuroscience’ outfits as the field breaks out from academia.

MORE

CHEMICAL & ENGINEERING NEWS
BIOTECH START-UP DIVIDE & CONQUER LAUNCHES TO DISRUPT CANCER CELL COMMUNICATION

SEPTEMBER 18th, 2019

Ryan Cross : In November 2014, biologist Miroslav Radman was thinking a lot about social networks, but not the kind we obsess over on our computers and phones. Instead, he was interested in the social networks of cells...

MORE

BIOCENTURY
DIVIDE & CONQUER: SHORT-CIRCUITING TUMOR LINES OF COMMUNICATION

SEPTEMBER 20th, 2019

Stephen Hansen : Divide & Conquer aims to capitalize on new tumor biology that would prevent cancer cells from sharing resistance mechanisms and resensitize the tumor to chemo- and radiotherapy....

MORE

LABIOTECH.EU
UK CANCER BIOTECH RAISES €11M SERIES A TO BREAK UP BRAIN TUMORS

SEPTEMBER 18th, 2019

Jonathan Smith : With this Series A round, funded by the UK VC firm Medicxi, Divide and Conquer has exited stealth mode a year after its foundation. The company will use the money to take its lead candidate drug for the treatment of glioblastoma to its first study in humans, expected to start by the end of 2020...

MORE

ENDPOINTS NEWS
'DISCONNECT THE BASTARDS'— ONE BIOTECH'S PLAN TO BREAK CANCER CELLS' UNIFIED DEFENSES

SEPTEMBER 18th, 2019

Chemotherapy and radiotherapy are the current gladiators of cancer treatment, but they come with well-known limitations and side-effects..

MORE

FIERCEBIOTECH
MEDICXI FOUNDS BIOTECH TO DIVIDE & CONQUER TOUGH SOLID TUMORS

SEPTEMBER 18th, 2019

Moncef Slaoui and his colleagues at Medicxi have taken the wraps off a new oncology startup, Divide & Conquer..

MORE

DRUGBARON
CELLULAR SOCIAL NETWORKS GIVE CANCER CELLS A CLOAK OF INVINCIBILITY

SEPTEMBER 18th, 2019

Ever since DrugBaron studied biochemistry at the end of the 1980s, one question about cancer has always perplexed him: why can we induce almost complete remission and yet the cancer can come back stronger and invariably kill the patient? ...

MORE

NATURE COVER STORY
BRAIN TUMOURS TAKE ROOT

SEPTEMBER 18th, 2019

Brain tumours are among the most lethal cancers. Primary brain tumours called malignant gliomas...

MORE

NATURE
GLUTOMATURGIC SYNAPTIC INPUT TO GLIOMA CELLS DRIVES BRAIN TUMOUR PROGRESSION

SEPTEMBER 18th, 2019

A paper by co-founder Prof. Frank Winkler and colleagues

MORE

PRESS RELEASE
DIVIDE & CONQUER EMERGES FROM STEALTH AS NEW PAPER BY CO-FOUNDER IS PUBLISHED IN NATURE

SEPTEMBER 18th, 2019

Cambridge, UK – 18 September 2019 : Divide & Conquer, a biotechnology company formed in 2018 with a £10 million (approximately $13.1 million) Series A financing from Medicxi, has left stealth mode to mark the publication of another paper in Nature co-authored by one of its founders, Prof. Frank Winkler of Heidelberg University...

MORE